Common Laboratory Abnormalities After Massive Transfusion
The most common laboratory abnormalities following massive transfusion (≥10 units packed red cells within 24 hours) are thrombocytopenia, coagulopathy (prolonged PT/PTT), and hypocalcemia, with these abnormalities occurring predictably based on the volume of blood products administered.
Hematologic Abnormalities
Thrombocytopenia
- Thrombocytopenia (platelet count <50 × 10⁹/L) occurs in 75% of patients after transfusion of 20 or more units of red blood cell products 1
- This represents the most frequently abnormal hemostasis test in massively transfused patients, occurring in over 93% of cases when any laboratory abnormality is present 2
- The mechanism is primarily dilutional, as packed red blood cells contain minimal platelets 1
Coagulopathy
- Clinically significant PT prolongation (>1.5 times mid-range normal) occurs in 100% of patients after 12 units of relatively plasma-free red blood cell products (packed RBCs or cell-saver units) 1
- PT prolongation is the second most frequently abnormal test after platelet count 2
- PTT prolongation follows a similar pattern, though PT is typically affected earlier 1, 2
- Coagulopathy develops in more than 70% of trauma patients receiving massive transfusion with AS-1 red cells 3
Metabolic and Electrolyte Abnormalities
Hypocalcemia
- Ionised calcium levels must be monitored and maintained within normal range (1.1–1.3 mmol/L) during massive transfusion 4
- Hypocalcemia results from citrate-mediated chelation of serum Ca²⁺, with each unit of pRBC or FFP containing approximately 3 grams of citrate 4
- In hemorrhagic shock requiring massive transfusion, liver hypoperfusion impairs citrate metabolism, exacerbating hypocalcemia 4
- Ionised calcium levels below 0.9 mmol/L should be corrected promptly; levels below 0.8 mmol/L are associated with cardiac dysrhythmias 4
- Hypocalcemia within the first 24 hours can predict mortality and need for multiple transfusions with greater accuracy than fibrinogen levels, acidosis, or platelet count 4
Hyperkalemia
- Transiently increased potassium values (5.2 ± 0.3 mmol/L) occur during rapid transfusion phases (>0.3 mL/kg/min) 5
- Hyperkalemia correlates significantly with potassium load from transfused blood (r = 0.64) 5
- Risk is particularly elevated in patients undergoing abdominal aortic surgery, even without concurrent shock, acidosis, or hypothermia 5
Acid-Base Disturbances
- Metabolic alkalosis develops after the massive transfusion phase, with significantly elevated base excess and pH compared to patients receiving fewer transfusions 5
- This contrasts with the initial acidosis often present from hemorrhagic shock 5
Fibrinogen Abnormalities
- Plasma fibrinogen is the third most frequently abnormal coagulation parameter 2
- Hypofibrinogenemia occurs as a consequence of both dilution and consumption 6
- The inverse correlation between fibrinogen levels and number of transfusions suggests dilutional etiology in many cases 2
Clinical Implications and Monitoring
Timing of Abnormalities
- Coagulation factor replacement becomes necessary after 12 or more units of packed red blood cells or cell-saver blood 1
- Platelet replacement becomes necessary after 20 or more units of any red blood cell product 1
- More than 40% of patients with exsanguinating hemorrhage or brain injuries have abnormal coagulation tests on admission, before massive transfusion begins 3
Additional Considerations
- Hypothermia, platelet dysfunction, and excessive fibrinolysis contribute to bleeding beyond simple dilutional effects 6
- Antiplatelet agents (e.g., clopidogrel) and hemostatic inhibitors (low-molecular-weight heparins, direct thrombin inhibitors) are contributing factors to bleeding 6
- Serial coagulation testing is recommended rather than fixed transfusion protocols, as indiscriminate administration of blood components based on preestablished schemes has not proven effective in reducing abnormalities or blood product requirements 2